Meloxicam (intravenous)

meloxicam · Yangtze River Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Meloxicam (intravenous), covering 2025-04-01 to 2025-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery [Phase 3]

See pricing